Securities code: Shanghai Rightongene Biotechnology Co.Ltd(688217) securities abbreviation: Shanghai Rightongene Biotechnology Co.Ltd(688217) Announcement No.: 2022004 Shanghai Rightongene Biotechnology Co.Ltd(688217)
Announcement of resolutions of the second meeting of the second board of supervisors
The board of supervisors and all supervisors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal liabilities for the authenticity, accuracy and integrity of its contents according to law.
1、 Meetings of the board of supervisors
Shanghai Rightongene Biotechnology Co.Ltd(688217) (hereinafter referred to as “the company”) the second meeting of the second session of the board of supervisors was held in the company’s conference room on March 10, 2022 by means of on-site combined communication. According to the relevant provisions of the articles of association, due to the emergency of this meeting, the notice of this meeting was sent by communication on March 8, 2022. The meeting was convened and presided over by Mr. Li yunhang, chairman of the board of supervisors. There should be 3 supervisors and 3 actual supervisors. The convener has explained the emergency meeting at the meeting, and all supervisors unanimously agreed to waive the notice time limit of the meeting. The convening and convening of this meeting comply with the company law of the people’s Republic of China and other laws, regulations, normative documents and the relevant provisions of the articles of association, and the resolutions formed are legal and effective.
2、 Deliberation at the meeting of the board of supervisors
After voting by the supervisors attending the meeting, the following resolutions were considered and adopted:
(I) deliberated and passed the proposal on the company’s restricted stock incentive plan in 2022 (Draft) and its summary
The contents of the company’s restricted stock incentive plan (Draft) for 2022 and its abstract comply with the company law, the securities law of the people’s Republic of China, the measures for the administration of equity incentive of listed companies, the rules for the listing of shares on the science and Innovation Board of Shanghai Stock Exchange, the self regulatory guide for listed companies on the science and Innovation Board No. 4 – disclosure of equity incentive information and other relevant laws Regulations and normative documents. The implementation of this incentive plan will be conducive to the sustainable development of the company, and there will be no damage to the interests of the company and all shareholders.
Voting: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
For details, please refer to the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) The Shanghai Rightongene Biotechnology Co.Ltd(688217) 2022 restricted stock incentive plan (Draft) and the summary announcement of Shanghai Rightongene Biotechnology Co.Ltd(688217) 2022 restricted stock incentive plan (Draft) (Announcement No.: 2022005).
(II) deliberated and passed the proposal on the management measures for the implementation and assessment of the company’s restricted stock incentive plan in 2022
The company’s management measures for the implementation and assessment of the restricted stock incentive plan in 2022 comply with the provisions of relevant laws and regulations and the actual situation of the company, and can ensure the smooth implementation of the company’s restricted stock incentive plan in 2022.
Voting: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
For details, please refer to the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Administrative measures for the implementation and assessment of Shanghai Rightongene Biotechnology Co.Ltd(688217) 2022 restricted stock incentive plan. (III) the proposal on verifying the list of incentive objects granted for the first time by the company’s restricted stock incentive plan in 2022 was deliberated and adopted
After the preliminary verification of the list of incentive objects of the company’s restricted stock incentive plan in 2022, the board of supervisors believes that the personnel listed in the list of incentive objects of the company’s restricted stock incentive plan have the qualifications specified in the company law, other laws, regulations and normative documents and the articles of Association, There is no case that the stock exchange has identified it as an inappropriate candidate within the last 12 months; There is no situation in which the CSRC and its dispatched offices have identified them as inappropriate candidates in the last 12 months; There are no cases in which the CSRC and its dispatched offices have imposed administrative penalties or taken market entry prohibition measures for major violations of laws and regulations in the last 12 months; There is no circumstance that the company is not allowed to serve as a director or senior manager of the company as stipulated in the company law; There is no case that the company is not allowed to participate in the equity incentive of listed companies according to laws and regulations. It meets the incentive object conditions specified in the measures for the administration of equity incentive of listed companies and the Listing Rules of science and Innovation Board of Shanghai Stock Exchange, and the scope of incentive objects specified in the company’s restricted stock incentive plan 2022 (Draft) and its abstract. Its subject qualification as the incentive object of the company’s restricted stock incentive plan is legal and effective.
The company will publicize the names and positions of incentive objects within the company through the company’s website or other channels before the general meeting of shareholders, and the publicity period shall not be less than 10 days. The board of supervisors will disclose the verification opinions on the list of incentive objects and the explanation of their publicity five days before the shareholders’ meeting deliberates the equity incentive plan.
Voting: 3 in favor, 0 against and 0 abstention.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) published by the company on the same day List of incentive objects first granted under the Shanghai Rightongene Biotechnology Co.Ltd(688217) 2022 restricted stock incentive plan.
It is hereby announced.
Shanghai Rightongene Biotechnology Co.Ltd(688217) board of supervisors March 12, 2022
